lasers in the dental, dermatology, plastic surgery and anti-aging
markets; MedX will continue direct distribution for the U.S.
Advertisement
Rehabilitation Market
MISSISSAUGA, ON, July 17 /PRNewswire-FirstCall/ - MedX Health Corp. (TSXV: MDX) today announced an exclusive distribution agreement with Technology4Medicine, a newly formed laser company based in San Clemente, CA, for the U.S. dental, dermatology, plastic surgery and anti-aging markets. Technology4Medicine will sell MedX Health's newest laser product, Oralase(TM) immediately upon clearances from the Food and Drug Administration to dental offices. Oralase is a low level laser therapy (LLLT) exclusively designed for dentists to alleviate pain and accelerate tissue repair following dental procedures.
Advertisement
"This partnership fulfills a key component of our vision for growth and we are pleased to enter into this agreement with an exciting new company such as Technology4Medicine," said Steve Guillen B.Sc., M.B.A., President & CEO, MedX Health. "As we move forward with our business plan to become the worldwide leader in light technology, MedX is committed to choosing the right partners to accelerate product distribution while continuing to develop superior products and explore new therapeutic opportunities for those products. We believe that Technology4Medicine is the right partner to penetrate the dental and other related markets in the United States through their specialized, experienced sales staff."
"MedX is already well established in the rehabilitation market, offering innovative laser and light therapy products that have successfully treated pain, sports injuries and other conditions," continued Guillen. "We believe our products can offer patients with acute and chronic wounds a non-invasive, drug free solution and we fully intend to pursue these indications aggressively."
The terms of the agreement include MedX giving Technology4Medicine exclusive U.S. rights to sell Oralase and other MedX lasers that may be applicable in the dental, dermatology, plastic surgery and anti-aging markets. Increased levels of promotion are expected to cross over into these other large growth markets.
"This agreement helps put Technology4Medicine on the forefront of laser product distribution," stated Jeff Jones, chief executive officer of Technology4Medicine. "We chose MedX as our partner to bring the many benefits of laser therapy to the US dental, aesthetic and other markets. This is a very impressive technology that will further establish our company in the dental industry with the best technology available. With Oralase, we believe we have a winning formula for quick uptake and use in this $1 Billion marketplace. The application of other MedX products in key U.S. markets such as aesthetic, anti-aging and dermatology, makes this a very attractive partnership."
About Oralase(TM)
-----------------
Oralase is an ergonomically designed portable low level laser device that offers dental staff a proven, drug-free solution to eliminate pain and accelerate soft and hard tissue repair. Oralase is designed to effectively control pain and decrease swelling from invasive dental procedures as well as stimulate healing. MedX has submitted to the FDA for marketing approval.
MedX has developed products designed specifically for the dental market. These products consist of the Oralase 200mw portable dental laser with interchangeable intra-oral probes, an Oralase console system with three accessories treating both intra and extra -orally, controlled by the compact Model 1100 console, the MedX Home portable system for extra-oral treatment, and the Oralase portable.
The MedX dental product line offers dental staff a proven, drug free solution to eliminate pain and accelerate soft and hard tissue repair.
